Evaluation of the viQtor Monitoring Solution on Surgical Wards
Launched by CATHARINA ZIEKENHUIS EINDHOVEN · Aug 26, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
The REQUEST study is looking at a new wireless monitoring device called the viQtor solution in a surgical ward at Catharina Hospital Eindhoven. This device continuously tracks important health signs like heart rate, breathing rate, and blood oxygen levels in patients after surgery. The main goal is to see if using the viQtor can help doctors detect any health issues earlier and also make things easier for nurses by reducing the number of manual checks they need to do. The study will include 500 patients over a period of 7 months.
To participate, patients need to be at least 18 years old and staying in the surgical ward at Catharina Hospital Eindhoven. They should also be comfortable communicating in Dutch or English and willing to wear the viQtor device during their hospital stay. However, some patients may not be eligible, such as those with cognitive impairments, certain allergies, or specific medical devices implanted in their bodies. If you join the study, you can expect to wear this monitoring device, which aims to help keep a closer eye on your health while you're recovering in the hospital.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients (18 years and older).
- • Patients admitted to the surgical ward at Catharina Hospital Eindhoven.
- • Fluent in Dutch or English.
- • Willingness to participate in the study and to wear the viQtor monitoring device during their hospital stay.
- Exclusion Criteria:
- • Patients with cognitive impairments.
- • Patients with allergies to metal or plastics.
- • Patients with significant deformities, swelling, irritation, degenerative changes, or edema of the upper arm.
- • Patients with implanted cardiac pacemakers, internal cardioverter defibrillators, or chronic resynchronization therapy devices.
- • Patients at risk of vascular compromise of the arm on which the device will be placed.
- • Patients with conditions that contraindicate the use of a blood pressure cuff or similar devices.
About Catharina Ziekenhuis Eindhoven
Catharina Ziekenhuis Eindhoven is a leading healthcare institution in the Netherlands, dedicated to delivering high-quality patient care and advancing medical research. As a prominent clinical trial sponsor, the hospital is committed to facilitating innovative research initiatives that aim to improve treatment outcomes and enhance patient quality of life. With a diverse range of medical specialties and a collaborative approach, Catharina Ziekenhuis Eindhoven fosters an environment that supports rigorous clinical trials, ensuring adherence to ethical standards and regulatory guidelines while prioritizing patient safety and well-being. Through its robust infrastructure and expertise, the hospital actively contributes to the development of new therapies and medical technologies, playing a vital role in the evolution of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Eindhoven, Noord Brabant, Netherlands
Patients applied
Trial Officials
Simon S.W. Nienhuijs, Dr. PHD.
Principal Investigator
Catharina Ziekenhuis Eindhoven
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported